z-logo
open-access-imgOpen Access
Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia
Author(s) -
Xiangwei Liu,
Xiaolei Sun,
Hua Liao,
Zhen Dong,
Jingjing Zhao,
Hong Zhu,
Peng Wang,
Liguo Shen,
Lei Xu,
Xin Ma,
Cheng Shen,
Fan Fan,
Cong Wang,
Kai Hu,
Yunzeng Zou,
Junbo Ge,
Jun Ren,
Aijun Sun
Publication year - 2015
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.306012
Subject(s) - aldh2 , angiogenesis , bone marrow , medicine , vascular endothelial growth factor , ischemia , aldehyde dehydrogenase , progenitor cell , transplantation , endocrinology , stem cell , biology , microbiology and biotechnology , biochemistry , gene , vegf receptors
Revascularization is an essential process to compensate for cardiac underperfusion and, therefore, preserves cardiac function in the face of chronic ischemic injury. Recent evidence suggested a vital role of aldehyde dehydrogenase 2 (ALDH2) in cardiac protection after ischemia. This study was designed to determine whether ALDH2 regulates chronic ischemia-induced angiogenesis and to explore the underlying mechanism involved. Moreover, the clinical impact of the ALDH2 mutant allele on the development of coronary collateral circulation (CCC) was evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom